Physician profile
Daniel P Gray
NPI 1811166366
$488.77
in general payments reported to CMS, 2019-2025
11 companies · $68.36 in 2025
The $68.36 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $18.28 · 2022: $144 · 2023: $91.41 · 2024: $166 · 2025: $68.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $326.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $141.23 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Novartis Pharmaceuticals Corporation | $81.46 | 2022-2023 | |
| Boston Scientific Corporation | $54.06 | 2024 | |
| Abbvie INC. | $51.78 | 2022-2025 | |
| Edwards Lifesciences Corporation | $38.50 | 2023-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.19 | 2023 | Jardiance |
| Dexcom, INC. | $23.31 | 2024 | Dexcom G6 Transmitter |
| Medtronic, INC. | $19.95 | 2025 | Kyphon Express II Kyphopak Tray |
| Ultragenyx Pharmaceutical INC. | $18.37 | 2022 | |
| Abbott Laboratories | $15.53 | 2022 | |
| Insightec,INC | $11.39 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Gray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.